BBG Advanced Therapies and CELLforCURE Partner to Provide Transatlantic Manufacturing Solutions for Advanced Therapy Medicinal Products (ATMPs)

CC chemokine receptor 5 deletion impairs macrophage activation and induces adverse remodeling following myocardial infarction

Leave a Reply

Your email address will not be published. Required fields are marked *